Abstract:Objective: We aimed to determine the outcome-driven thresholds for central systolic blood pressure (cSBP) based on the new ACC/AHA hypertension classification and to explore the characteristics and prognosis associated with central systolic hypertension (cSHT). Design and method: In 5580 participants enrolled from 9 populations (mean age 54.2 years; 54.1% women), cSBP was estimated tonometrically from the radial waveform (SphygmoCor, Atcor, Australia). We determined the thresholds for cSBP, resulting in 5-year cardiovascular risks similar to those associated with the 2017 ACC/AHA classification of brachial systolic blood pressure (bSBP). Statistical methods included analysis of covariance, the log-rank test and proportional hazards regression. Results: Over 4.1 years (median), 203 persons died (6.4 per 1000 person years) and 252 experienced a composite cardiovascular endpoint (8.2 per 1000 person-years). After rounding to the nearest 5 mm Hg, approximate thresholds for elevated cSBP and stages 1 and 2 and severe cSHT were 110, 120, 130 and 150 mm Hg, respectively. In 3659 untreated subjects, those with isolated cSHT (cSBP > = 120 mmHg, n = 137, 3.7%), compared to the participants with central (cSBP < 120 mmHg) and brachial (bSBP <130 mmHg) normotension (n = 1953, 53.4%), were older, more likely being female, had smaller height, slower heart rate and higher augmentation index. The opposite was true for isolated brachial hypertension (bSHT; bSBP > = 130 mmHg, n = 192, 5.3%). Among 1921 treated patients, the use of b-blockers was more frequent (50% vs. 36.2%, P = 0.027), whereas in isolated cSHT (n = 72, 3.8%) compared with controlled cSBP, RAAS inhibitors less often used (50% vs. 65.3%, P = 0.013). Among all participants, with brachial and central normotension as reference, the multivariable-adjusted hazard ratios (95% confidence interval) of the composite cardiovascular events were 1.29 (0.57–2.90; P = 0.54) for isolated bSHT, 2.30 (1.22–4.33; P = 0.01) for isolated cSHT, and 2.00 (1.39–2.88; P = 0.002) for concordant cSHT and bSHT. Conclusions: Outcome-driven thresholds of central systolic BP were approximately 10 mm Hg lower than their brachial counterparts. cSHT, either isolated (4%) or combined bSHT (90%), was characterised by greater systolic augmentation and was associated with higher cardiovascular risk.

RISK STRATIFICATION BY CROSS-CLASSIFICATION OF CENTRAL AND BRACHIAL SYSTOLIC BLOOD PRESSURE

OUTCOME-DRIVEN THRESHOLDS OF CENTRAL SYSTOLIC BLOOD PRESSURE AND CROSS-CLASSIFICATION OF SYSTOLIC HYPERTENSION AT CENTRAL AND BRACHIAL ARTERIES

Risk Stratification by Ambulatory Blood Pressure Monitoring Across Jnc Classes of Conventional Blood Pressure

BLOOD PRESSURE CLASSIFICATION USING BRACHIAL VERSUS CENTRAL HYPERTENSION PHENOTYPES AND ASSOCIATION WITH LEFT VENTRICULAR MASS – FINDINGS FROM THE I24ABC CONSORTIUM

Cardiovascular End Points and Mortality Are Not Closer Associated With Central Than Peripheral Pulsatile Blood Pressure Components

Central Rather Than Brachial Pressures Are Stronger Predictors of Cardiovascular Outcomes: A Longitudinal Prospective Study in a Chinese Population.

Beat-to-beat, Reading-to-reading, and Day-to-day Blood Pressure Variability in Relation to Organ Damage in Untreated Chinese

Central hypertension is a non‐negligible cardiovascular risk factor

The International Database of Central Arterial Properties for Risk Stratification: Research Objectives and Baseline Characteristics of Participants

Brachial and Central Hypertension in Relation to Coronary Stenosis in Patients with Coronary Angiography.

Independent and Joint Effect of Central and Brachial SBP on Incident Stroke in Hypertensive Adults

Prevalence of Central Hypertension and Its Association with Target Organ Damage in Untreated Chinese Patients

Ambulatory Hypertension Subtypes and 24-Hour Systolic and Diastolic Blood Pressure As Distinct Outcome Predictors in 8341 Untreated People Recruited from 12 Populations.

Ambulatory Blood Pressure Monitoring in 9357 Subjects from 11 Populations Highlights Missed Opportunities for Cardiovascular Prevention in Women

Association of cardiovascular events with central systolic blood pressure: A systemic review and meta‐analysis

Clusters of risk factors in metabolic syndrome and their influence on central blood pressure in a global study

The Prevalence of Central Hypertension Defined by a Central Blood Pressure Type I Device and Its Association with Target Organ Damage in the Community-Dwelling Elderly Chinese: the Northern Shanghai Study.

Examining the Linear Association Between Blood Pressure Levels and Cardiovascular Diseases in the Absence of Major Risk Factors in China

Independent and Joint Effect of Central and Brachial Systolic Blood Pressure on Incident Stroke in Hypertensive Adults

A18029 Outcome-Driven Thresholds for Ambulatory Blood Pressure Based on the New ACC/AHA Classification of Hypertension

A0504 the Prevalence of Central Hypertension and Its Association with Target Organ Damage in Community-Dwelling Elderly Chinese